2
Tetrahedron
Completion of the synthesis involved the demethylation of
6. To a solution of 5 (180 mg, 0.789 mmol) in DMF (0.7 mL)
was added 37% aq. succinaldehyde (0.917 mL, 3.94 mmol) and
catalytic methyl piperidine (0.2 mL). The mixture was stirred at
140 °C for 5h. The mixture was cooled to RT and quenched with
water. The mixture was extracted with DCM (3x) and the
combined organic layer was washed with brine, dried with
anhydrous sodium sulfate, and concentrated under reduced
pressure. The crude mixture was purified by normal phase
column chromatography by MPLC using EtOAc in cyclohexane
(0 to 50%) to obtain the target material 6 in 86% yield (158.3
mg).
benzopyrone 6 using BCl3 to afford the racemic diaportheone A8
in 82% yield. Chiral separation by preparative HPLC9 obtained
the enantiomers (+)-(S)-1a (ent-diaportheone A) ([α]D 25 = +130o
(c. 1.0, CHCl3)) and ()-(R)-1 (diaportheone A) ([α]D 25 = 130o
(c. 1.0, CHCl3)) in 99% ee. Unambiguous determination of the
absolute configuration of the ()-(R)-1 was done by X-ray
crystallography (Fig. 4).
1H NMR (400 MHz, CDCl3) δ 7.53 (t, J = 8.4 Hz, 1H), 7.04 (dd,
J = 8.5, 1.0 Hz, 1H), 6.83 (d, J = 8.3 Hz, 1H), 5.43 (ddd, J = 7.8,
4.0, 1.5 Hz, 1H), 3.98 (s, 3H), 3.05 (dddd, J = 17.8, 9.7, 4.4, 1.5
Hz, 1H), 2.82 (ddd, J = 17.8, 9.3, 5.7 Hz, 1H), 2.50 (dddd, J =
13.7, 9.1, 7.8, 4.3 Hz, 1H), 2.00 (dddd, J = 13.7, 9.7, 5.6, 4.0 Hz,
1H).
7. The chiral separation of rac-6 was done by preparative SFC
method using Chiralpak IG column (5 μm, 250 x 30 mm) using
CO2:[MeOH+0.1%NH3] 45:55 (v:v) as mobile phase. The
flowrate was set at 1.00 mL/min and UV detection at 220 nm.
Both enantiomers were separated in >99% ee. The specific
rotation of 6a was found to be []D 25 = +110o (c. 1.0, CHCl3) and
6b is []D 25 = 126o (c. 1.0, CHCl3).
Fig 4. X-ray crystallography of synthetic 1.
1
8. H NMR (400 MHz, CDCl3) δ 12.40 (s, 1H), 7.49 (t, J = 8.3
Based on these results, the absolute configuration of the
Hz, 1H), 6.90 (dd, J = 8.4, 0.9 Hz, 1H), 6.80 (dd, J = 8.2, 0.9 Hz,
1H), 5.46 (ddd, J = 7.7, 3.4, 1.4 Hz, 1H), 3.14 (dddd, J = 18.2,
9.4, 5.2, 1.5 Hz, 1H), 2.85 (ddd, J = 18.2, 9.4, 4.9 Hz, 2H), 2.52
(dddd, J = 14.3, 9.4, 7.6, 5.1 Hz, 1H), 2.05 (dddd, J = 14.1, 9.2,
4.9, 3.3 Hz, 1H).
9. The chiral separation of rac-diaportheone A was done by
preparative HPLC method using Chiralpak AY-H column (5 μm,
250 x 30 mm) using Heptane : EtOH 85:15 as mobile phase. The
flowrate was set at 1.00 mL/min and UV detection at 220
nm.Both enantiomers were separated in 99% ee. The specific
rotation of 2 was found to be []D 25 = +130o (c. 1.0, CHCl3) and 2
is []D 25 = 130o (c. 1.0, CHCl3).
25
natural diaportheone A ([]D = 52o (c. 0.08, CHCl3))2 was
determined to be R in comparison of the optical rotation of the
synthetic enantiomers with the natural product. The NMR data
including the high resolution spectrometric data is in excellent
agreement with the natural product diaportheone A. The
synthesis of diaportheone A was completed in four steps and
46% over-all yield.
Conclusion
The total synthesis and elucidation of the absolute configuration
of enantiopure diaportheone A (1) was completed. All chiral
compounds (benzopyrones 6a and 6b, and diaportheone A (1)
and ent-diaportheone
A
(1a) were obtained in >99%
enantiomeric excess. The absolute configuration of diaporthone
A was established to be C-1R.
Acknowledgments
The Global Scientific Capabilities Centre of Excellence in Global
Drug Development, Novartis Pharma, the Global Health Office
in Novartis Institutes for BioMedical Research, Basel,
Switzerland, X-ray crystallography unit, and the Separations
Laboratory, NIBR GDC are gratefully acknowledged.
References and notes
1. (a) Gaspar A, Matos MJ, Garrido J, Uriarte E, Borges F.
Chem. Rev. 2014; 114: 4960-4992; (b) Reis J, Gaspar A,
Milhazes N, Borges F. J. Med. Chem. 2017; 60: 7941-7957
2. Bungihan M, Tan MA, Kitajima M, Kogure N, Franzblau S,
dela Cruz, TE, Takayama H, Nonato MG. J. Nat. Med. 2011; 65:
606-609.
3. Swaroop P, Raut G, Gonnade R, Verma P, Gokhale R,
Srinivasa Reddy D. Org. Biomol. Chem. 2012; 10: 5385-5394.
4. Mori K, Audran G, Monti H. Synlett. 1998; 259-260
5. Klutchko S, Cohen M-P, Shavel J-R, Von Strandtmann M. J.
Heterocyclic Chem. 1974; 11: 183-188.